Characterization of messenger RNA from epimastigotes and metacyclic trypomastigotes of Trypanosoma cruzi  by Goldenberg, S. et al.
Volume 180, number 2 FEBS 2214 January 1985 
Characterization of messenger RNA from epimastigotes 
and metacyclic trypomastigotes of Trypanosoma cruzi 
S. Goldenberg, J.M. Salles+, V.T. Contreras *, M.P. Lima France+, A.M. Katzin”, W. Colli” and 
C.M. Morel 
Department of Biochemistry and Molecular Biology, Institute Oswald0 Cruz, Avenida Brasil4365.21040 Rio de Janeiro, 
Brazil 
Received 6 November 1984 
The cell-free translation products of polyribosomal and post-polyribosomal mRNAs from the non-infective 
epimastigotes and the infective metacyclic trypomastigotes of the parasitic protozoan Trypanosoma cruzi 
were compared by two-dimensional polyacrylamide gel electrophoresis. The result show that although many 
polypeptides are conserved, quantitative and qualitative differences are observed between both differentia- 
tion stages. The results also indicate the existence of post-polyribosomal mRNAs in equilibrium with polyri- 
bosomal counterparts. The immunoprecipitation of the in vitro synthesized polypeptides with chagasic hu- 
man serum and the serum raised against an 85kDa glycoprotein (PZ-WGA), potentially involved in the 
process of T. cruzi penetration into mammalian cells, shows that while the chagasic serum recognizes the 
same 72-kDa, 6%kDa and 46-kDa polypeptides in both differentiation stages, the anti-PZWGA serum im- 
munoprecipitates a single 48-kDa polypeptide from in vitro translation products of metacyclic trypomasti- 
gotes. 
T. cruzi mRNA Cell-free translation Surface antigen Chagas’ Disease 
1. INTRODUCTION 
Trypanosoma cruzi, the etiological agent of 
American trypanosomiasis, also known as Chagas’ 
disease, possesses a life-cycle involving mam- 
malian and insect hosts, comprising various mor- 
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phological and functional types. The principal 
features of this cycle are: infected hematophagous 
reduviidae insects (triatomines) bite the mammal 
releasing metacyclic trypomastigotes in the ex- 
creta. Metacyclics invade the mammal through the 
wound or mucosa and penetrate or are phagocy- 
tized by the mammalian host cells. Inside the host 
cell, metacyclic trypomastigotes are transformed 
to the non-flagellated amastigotes prior to replica- 
tion, as the infective form T. cruzi does not 
replicate. The amastigotes are transformed again 
into trypomastigotes which are released from the 
infected cell. Once in the blood stream, 
trypomastigotes either invade new cells or may be 
ingested by the reduviidae insect. In the latter case, 
they are transformed into the replicative 
epimastigotes in the insect midgut, completing 
their life-cycle and being finally released as 
metacyclic trypomastigotes in the excreta of the in- 
sect [ 1,2]. 
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As yet, very little is known about the molecular 
mechanisms involved in control of gene expression 
within T. cnrzi. We have recently observed that 
stage-specific gene expression precedes the mor- 
phological changes which occur in the differentia- 
tion of epimastigotes to metacyclic trypomasti- 
gotes [3]. This differentiation must involve the ex- 
pression of stage-specific genes and among them 
those coding for surface antigens. 
Here, we pursue our investigation of the dif- 
ferentiation of T. cruzi epimastigotes to metacyclic 
trypomastigotes by comparing the in vitro transla- 
tion products of polyribosomal and post- 
polyribosomal poly(A)+ mRNAs from both dif- 
ferentiation stages. Furthermore, in vitro transla- 
tion polypeptides are characterized by their im- 
munoprecipitation with human chagasic serum 
and with the serum raised against the 85-kDa 
WGA-binding glycoprotein possibly involved in T. 
cruzi adhesion and penetration into mammalian 
cells 14-61. 
2. MATERIALS AND METHODS 
2.1. Cells 
T. cruzi Dm 28c cells 171 were grown in LIT 
medium 181 for 6 days without agitation. For 
trypomastigote induction epimastigotes from LIT- 
medium were incubated in TAUS for 6 days [3] 
and metacyclic trypomastigotes were finally 
purified on DEAE-cellulose [9]. 
2.2. Isolation of polyribosomes 
Cycloheximide (final concentration 10 pg/ml) 
was added to 5 x 10” cells in LIT or TAUS media 
30 min prior to harvesting. Cells were centrifuged 
at 8000 x g for 15 min at 10°C (Beckman rotor 
JA-14) and washed 3 times with 140 mM NaCl, 
5 mM KCl, 2 mM MgClz, 10 mM Hepes, pH 7.4, 
5 /cg/ml cycloheximide and 10 U/ml heparin. Cells 
were lysed in 5 vols of 10 mM NaCl, 5 mM MgClz, 
10 mM Tris-HCl, pH 7.6, 5 mM 2-mercaptoeth- 
anol, 5 pg/ml cycloheximide and 10 U/ml heparin 
for 3 min at 4’C with agitation. Sucrose and 
Nonidet P-40 were added to final concentrations 
of 0.25 M and 1070, respectively. Lysed cells were 
centrifuged at 2500 x g at 4°C followed by cen- 
trifugation at 10000 x g at 4°C for 30 min 
(Beckman JS 13 rotor). Polyribosomes were ob- 
tained by centrifugation of the post-mitochondrial 
266 
supernatant containing 0.5% sodium deoxycholate 
through a 1 M sucrose cushion at 365000 x g for 
90 min at 4°C (Beckman SW 50.1 rotor). 
2.3. Isolation of poly(A)” mRNAs 
Isolated polyribosomes or post-polyribosomal 
supernatants precipitated with ethanol, were made 
10 A260 units/ml in 10 mM Tris-HCl, pH 7.4, 
0.5% SDS and extracted by the hot phenol method 
[lo]. Poly(A)+ RNAs were isolated as in [ 111. 
2.4. mRNA in vitro translation and immuno- 
precipitation 
mRNA in vitro translation was performed in a 
nuclease-treated rabbit reticulocyte lysate [ 121. Im- 
munoprecipitation was performed as in [3]. 
2.5. Polyacrylamide gel electrophoresis 
One-dimensional SDS-polyacrylamide gel elec- 
trophoresis was performed in linear lo-15% gra- 
dients [ 131. Two-dimensional polyacryl~ide gel 
electrophoresis was performed using uniform 13% 
SDS-polyacrylamide gels in the second dimension 
[14]. Gels were treated for fluorography [15] and 
exposed to Sakura RX-films, using Kodak X-O- 
Matic intensifying screens. 
2.6. Reagents 
These were analytical grade and nuclease free. 
[35S]Methionine (1045 Ci/mmol) was from Amer- 
sham (England). Micrococcal nuclease was from 
P.L. Biochemicals and the other enzymes were 
from Sigma. Oligo(dT) cellulose was from Col- 
laborative Research Inc. 
3. RESULTS 
3.1. Analysis of in vitro translation products of 
polyribosomal mRNA 
The comparison, by two-dimensional poly- 
acrylamide gel electrophoresis, of the in vitro 
translation products directed by polyribosomal 
mRNAs from epimastigotes (fig.lA) and 
metacyclic trypomastigotes (fig. 1B) of T. cruzi 
Dm 28~ shows a complex polypeptide pattern. 
Some of the polypeptides are conserved in both 
differentiation stages (e.g., polypeptides l-6, 
fig. 1). However, quantitative (e.g., polypeptides 
7-12) and qualitative (e.g., polypeptides 13-17, 
fig. IA and 18-26, fig. 1B) differences are detected 
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Fig.1. Two-dimensional polyacrylamide gel electrophoresis of the in vitro translation products of: (A) epimastigote 
polyribosomal mRNA; (B) metacyclic trypomastigote polyribosomal mRNA; (C) epimastigote post-polyribosomal 
mRNA; (D) metacyclic trypomastigote post-polyribosomal mRNA. The first dimension is an isoelectric focusing and 
the second imension is a 13% SDS-polyacrylamide g l. 
between both differentiation stages. Some of the 
polypeptides specific to metacyclic trypomasti- 
gotes are faintly represented in the epimastigote 
mRNA in vitro translation products profile (e.g., 
polypeptides 23-26); this is probably due to the 
small percentage of metacyclic trypomastigotes 
normally found in epimastigote cultures [8] or to 
the presence of morphological epimastigotes 
displaying metacyclic trypomastigote gene expres- 
sion products [3]. Most of the epimastigote in vitro 
translation products are concentrated in the range 
pH 5.6-6.1 (fig.lA) while the metacyclic 
trypomastigote stage specific in vitro synthesized 
polypeptides are localized in the range pH 5.1-5.6. 
3.2. The existence of T. cruzi post-polyribosomal 
mRNAs 
To investigate whether T. cruzi polyribosomal 
mRNAs could be stored as non-polyribosomal 
mRNAs and whether mRNA sequences from a 
particular differentiation stage could be stored in 
the other form as non-translatable post- 
polyribosomal mRNA, we have analysed the in 
vitro translation products of post-polyribosomal 
poly(A)+ mRNAs from epimastigotes (fig. 1C) and 
from metacyclic trypomastigotes (fig.lD). The 
results show that although T. cruzi possesses 
mRNA stored in the cytoplasm, these mRNA se- 
quences are in equilibrium with the homologous 
polyribosomal population. As we will discuss later, 
we do not believe these post-polyribosomal 
mRNAs arise from polyribosome run-off. 
3.3. Immunoprecipitation of in vitro translation 
products 
The in vitro translation products from 
polyribosomal and post-polyribosomal mRNAs 
isolated from epimastigotes and from metacyclic 
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trypomastigotes were immunoprecipitated with 
human chagasic patient serum and with the serum 
raised in rabbits against the P2-WGA fraction 
which contains an almost pure 8%kDa giycopro- 
tein [S]. The human chagasic antiserum recognizes 
two major polypeptides of M, 72000 and 68000 
and minor polypeptides of Mr 82000, 55000, 
46000 and 32000 within epimastigote polyribo- 
somal and post-polyribosom~ mRNA in vitro 
translation products (fig.2, lanes A and B, respec- 
tively). Three polypeptides of M, 72 000,68 000 and 
MAB CD EFGB I JM 
Fig.2. Polyacrylamide gel electrophoresis of in vitro 
translation products of: (A) epimastigote poiyribosomal 
mRNA immunoprecipitated with chagasic sera; (B) 
epimastigote post-polyribosomal mRNA immuno- 
precipitated with chagasic sera; (C) metacyclic trypo- 
mastigote polyribosomal mRNA immunoprecipitated 
with chagasic sera; (D) metacyclic trypomastigote post- 
polyribosomal mRNA immunoprecipitated with 
chagasic sera; (E) epimastigote polyribosomal mRNA 
immunoprecipitated with human normal sera; (F) 
epimastigote polyribosomal mRNA immunoprecipitated 
with anti-P2 WGA sera; (G) epimastigote post- 
polyribosomal mRNA immunoprecipitated with anti-P2 
WGA sera; (H) metacyclic tr~omastigote polyribo- 
somal mRNA immunoprecipitated with anti-P2 WGA 
sera; (I) metacyclic trypomastigote post-polyribosomal 
mRNA immunoprecipitated with anti-P2 WGA sera; (J) 
metacyclic trypomastigote polyribosomal mRNA 
immunoprecipitat~ with rabbit normal sera; (M) 14C 
molecular mass markers of 92.5, 68, 43, 25.7, 18.4 and 
12.3 kDa. 
46000 are immunoprecipitated from metacyclic 
trypomastigote polyribosomal and post- 
polyribosomal mRNA in vitro translation products 
by the chagasic antiserum (fig.2, lanes C and D, 
respectively). The comparison of these results with 
those obtained for epimastigotes hows that fewer 
proteins are immunoprecipitated from metacyclic 
trypomastigotes and that there is a relative enrich- 
ment of the 46-kDa polypeptide in the metacyclic 
tr~omastigote immunoprecipitated polypeptides. 
Conversely, the immunoprecipitation of epimas- 
tigote and metacyclic trypomastigote mRNA in 
vitro translation products with the PZWGA an- 
tiserum recognizes specifically a 4%kDa polypep- 
tide within the in vitro synthesized proteins of 
polyribosomal mRNA from metacyclic trypo- 
mastigotes (fig.2, lane H). The fact that no poly- 
peptides are specifically immunoprecipitated either 
from epimastigote polyribosomal and post-poly- 
ribosomal mRNA in vitro translation products 
(fig.2, lanes F and G, respectively) or from 
metacyclic trypomastigote post-polyribosomal 
mRNA in vitro translation products (fig.2, lane I), 
indicates that the mRNA coding for this polypep- 
tide is stage specific and is not stored in the 
cytoplasm. The control immunoprecipitations with 
human and rabbit normal sera is shown in fig.2, 
lanes E and J, respectively. 
4. DISCUSSION 
The results point to the complexity of the 
mRNA population of T. crud non-infective 
epimastigotes and infective metacyclic trypomas- 
tigotes, contrasting with results obtained by others 
showing an extremely simple profile for the in vitro 
synthesized polypeptides [17]. Several mRNAs are 
conserved among both differentiation stages, in 
agreement with the fact that epimastigotes and 
metacyclic trypomastigotes must share common 
structural proteins and enzymes. Notwithstanding, 
differences are observed among mRNAs of both 
differentiation stages. These stage-specific gene ex- 
pression products could be involved in the 
biological properties characteristic of each T. cruzi 
differentiation form. 
The presence of mRNAs in the post- 
polyribosom~ supernatant is not surprising since 
this appears to be a common feature for different 
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eukaryotic cells [ 18,191. We do not believe that the 
post-polyribosomal mRNAs have been artifactual- 
ly generated both because run-off inhibitors 
(cycloheximide or emetine) have been used during 
cell manipulation and because one of the major 
polyribosomal mRNA in vitro translation products 
(polypeptide 1) is almost absent within the post- 
polyribosomal in vitro translation products. In the 
case of T. cruzi, these hitherto in vivo translation 
repressed mRNAs would be in equilibrium with 
counterparts being actively translated, contrasting 
with other cell systems (e.g., duck reticulocytes) 
where the analytical complexity of post- 
polyribosomal mRNAs is much greater than the 
polyribosomal population [20]. However, we can- 
not rule out the possibility that minor polypeptides 
have not been detected or, alternatively, that some 
T. cruzi mRNAs are not translatable in the 
reticulocyte lysate. Conversely, it has been shown 
that the intracellular transformation of T. cruzi 
trypomastigotes to amastigotes is performed 
without RNA synthesis [21], suggesting the ex- 
istence of stored mRNAs that would translate the 
new proteins required in the transformation pro- 
cess. In addition, it has been suggested that 
Leishmania mexicana tubulin mRNA is se- 
questered to the post-polyribosomal compartment 
during differentiation [22]. 
The immunoprecipitation of the in vitro transla- 
tion products with two different antisera shows 
that while human chagasic serum recognizes com- 
mon polypeptides of M, 72000, 68000 and 46000 
in all 4 mRNA populations, the anti-P2 WGA 
serum recognizes a single polypeptide of M, 48 000 
within the metacyclic trypomastigote polyriboso- 
ma1 mRNA population. As yet we cannot explain 
the difference in molecular mass of the in vivo 
85kDa protein [4-61 and the in vitro synthesized 
48-kDa polypeptide (fig.2, lane H). It could be at 
least partially due to the post-translational 
glycosylation of the polypeptide chain inside T. 
cruzi. Indeed, several T. cruzi proteins are post- 
translationally modified [23], implying that care 
must be undertaken when comparing T. cruzi in 
vivo and in vitro translation products [17]. 
Finally, the fact that sera raised against surface 
antigens relevant to T. cruzi penetration in mam- 
malian cells recognize polypeptidic epitopes raises 
the possibility of parasite antigen production by 
cDNA cloning in expression vectors. 
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